LanTing Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
United States, China, Switzerland
Industries Focus
- Healthcare
- Automotive
- Software
- Artificial Intelligence
- Pharmaceuticals
- Medical Devices
- Internet
- Robotics
- Information Technology
- Biotechnology
- Internet of Things
- Digital Entertainment
- Clinical Trials
- Consumer Health
- Smart Home
Investor Details Founded: 2017
LanTing Capital is a cross-border venture capital firm specializing in healthcare and pharmaceutical investments across China, the United States, and Europe. Founded by pharmaceutical veterans and asset management experts, the firm leverages its deep industry knowledge and extensive network to identify and support high-potential opportunities in the healthcare sector.
The firm's investment strategy encompasses various stages, including early-stage, growth, and late-stage investments, focusing on sectors such as biotechnology, medical devices, consumer health, robotics, clinical trials, internet of things, information technology, internet, smart home, software, artificial intelligence, automotive, and digital entertainment. LanTing Capital operates in key markets, including China, the United States, and Switzerland, providing a global perspective to its investment approach.
LanTing Capital's portfolio includes a diverse range of companies across the healthcare and technology sectors, reflecting its commitment to fostering innovation and growth in these industries. The firm's strategic approach combines financial expertise with a deep understanding of the pharmaceutical and healthcare landscapes, enabling it to navigate complex regulatory environments and create value for its portfolio companies and investors.
Requirements
- Focus on healthcare and pharmaceutical sectors
- Interest in cross-border growth opportunities
- Alignment with firm's investment stages and geographical focus
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Innogen Pharmaceutical
- Rona Therapeutics
- Yinuo Pharmaceutical
- Regor Therapeutics
- Yunji Technology
- Immvira
- Yuntongxun
- Green Rice Technology
- DeepTech
Mentioned In
-
$24.95
-
$49.95
-
$19.95
-
$39.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of LanTing Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim